Stockscreener 앱 받기
1.15
6.50%
-0.08
시간 외 거래:
1.18
0.03
+2.61%
전일 마감가:
$1.23
열려 있는:
$1.21
하루 거래량:
345.10K
Relative Volume:
0.51
시가총액:
$42.59M
수익:
-
순이익/손실:
$-25.94M
주가수익비율:
-0.8333
EPS:
-1.38
순현금흐름:
$-15.79M
1주 성능:
-16.67%
1개월 성능:
+15.00%
6개월 성능:
-30.72%
1년 성능:
-47.73%
1일 변동 폭
$1.1401
$1.25
1주일 범위
$1.1401
$1.75
52주 변동 폭
$0.87
$2.74
MAIA Biotechnology Inc Stock (MAIA) Company Profile
명칭
MAIA Biotechnology Inc
전화
312 416 8592
주소
444 West Lake Street, Suite 1700, Chicago
MAIA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MAIA
MAIA Biotechnology Inc
|
1.15 | 45.55M | 0 | -25.94M | -15.79M | -1.38 |
|
VRTX
Vertex Pharmaceuticals Inc
|
449.52 | 115.43B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
749.79 | 78.44B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
862.05 | 52.42B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
392.10 | 51.68B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
198.46 | 42.80B | 447.02M | -1.18B | -906.14M | -6.1812 |
MAIA Biotechnology Inc 주식(MAIA)의 최신 뉴스
MAIA Biotechnology Announces $2.25M Private Placement Deal - TipRanks
MAIA Biotechnology Announces $1.51 Million Private Placement - The Manila Times
MAIA Biotechnology, Inc. announced that it expects to receive $1.289791 million in funding - marketscreener.com
MAIA Biotechnology Announces Significant Insider Buying - TipRanks
MAIA Biotechnology, Inc. Announces Key Developments in Cancer Therapy - TradingView — Track All Markets
MAIA Biotechnology (NYSE American: MAIA) begins Phase 3 NSCLC study of telomere-targeting ateganosine - Stock Titan
MAIA Biotechnology Announces First Patient Dosed in THIO-104 Phase 3 Pivotal Trial Evaluating Ateganosine as Third-Line Treatment for Advanced Non-Small Cell Lung Cancer - Yahoo Finance
MAIA Leadership Continues Insider Buying in 2025 and Trial Data Signals Breakout Potential - GlobeNewswire
MAIA Biotechnology announces significant insider buying - MSN
MAIA Biotechnology Advances NSCLC Treatment with Ateganosine - TipRanks
MAIA Biotechnology, Inc. Targets $50B Immunotherapy Market with New Approach - TradingView — Track All Markets
MAIA Takes Aim at a $50B Immunotherapy Market with Breakthrough Telomere-Targeting Approach - The Manila Times
MAIA Biotechnology (NYSE American: MAIA) starts Phase 3 telomere drug trial in NSCLC - Stock Titan
Prepare Yourself for Liftoff: MAIA Biotechnology Inc (MAIA) - setenews.com
Director Makes Bold Move with Major Stock Purchase in MAIA Biotechnology! - TipRanks
Can MAIA Biotechnology Inc. stock sustain revenue momentum2025 Price Targets & Real-Time Price Movement Reports - Newser
How MAIA Biotechnology Inc. stock reacts to bond yieldsWeekly Gains Summary & Free Technical Pattern Based Buy Signals - Newser
Vlad Vitoc, Maia Biotech CEO, buys $79,848 in Maia stock By Investing.com - Investing.com Australia
Vlad Vitoc, Maia Biotech CEO, buys $79,848 in Maia stock - Investing.com
Is MAIA Biotechnology Inc. stock among top earnings plays2025 Stock Rankings & Daily Chart Pattern Signals - Newser
How MAIA Biotechnology Inc. stock compares with top peersMarket Trend Summary & Fast Gain Swing Alerts - Newser
Vitoc Vlad, CEO of Maia Biotechnology, buys $10k in shares - Investing.com Canada
Why hedge funds are buying MAIA Biotechnology Inc. stockRisk Management & Daily Risk Controlled Trade Plans - Newser
MAIA Biotechnology Inc (MAIA) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - setenews.com
How MAIA Biotechnology Inc. stock responds to policy changesTrade Analysis Report & Daily Risk Controlled Trade Plans - Newser
Will MAIA Biotechnology Inc. stock return to pre crash levels2025 Bull vs Bear & Smart Allocation Stock Reports - Newser
How MAIA Biotechnology Inc. stock compares with market leaders2025 Technical Overview & Weekly High Return Stock Forecasts - Newser
Will MAIA Biotechnology Inc. stock recover faster than industryAnalyst Upgrade & Safe Entry Zone Tips - Newser
Why MAIA Biotechnology Inc. stock could rally stronglyJuly 2025 Snapshot & Free Low Drawdown Momentum Trade Ideas - Newser
Top Executives Make Bold Moves with Major Stock Purchases at MAIA Biotechnology! - TipRanks
Maia Biotechnology announces open market purchases by CEO and directors - marketscreener.com
MAIA Biotechnology Announces Open Market Purchases by CEO and Directors - The Manila Times
Vitoc Vlad buys MAIA biotechnology (MAIA) shares worth $79,848 By Investing.com - Investing.com Australia
Luput Cristian, director at Maia Biotechnology, buys $41,845 in shares By Investing.com - Investing.com South Africa
Smith Stan, MAIA Biotechnology director, buys $15,582 in shares By Investing.com - Investing.com South Africa
Vitoc Vlad buys MAIA biotechnology (MAIA) shares worth $79,848 - Investing.com India
Smith Stan, MAIA Biotechnology director, buys $15,582 in shares - Investing.com
MAIA Biotechnology Executives Increase Holdings - TradingView — Track All Markets
Luput Cristian, director at Maia Biotechnology, buys $41,845 in shares - Investing.com
MAIA Biotechnology Inc (MAIA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.18%
0.62%
자본화:
|
볼륨(24시간):